Literature DB >> 3286344

Increased proinsulin levels as an early indicator of B-cell dysfunction in non-diabetic twins of type 1 (insulin-dependent) diabetic patients.

D A Heaton1, B A Millward, I P Gray, Y Tun, C N Hales, D A Pyke, R D Leslie.   

Abstract

Glucose tolerance and insulin secretion were studied in two groups of non-diabetic identical twins of recently-diagnosed Type 1 (insulin-dependent) diabetic patients: (1) a group of 5 twins with islet cell antibodies, and (2) a group of 6 twins without. Despite similar fasting glucose, insulin and C-peptide concentrations both groups of twins had significantly higher fasting proinsulin concentrations than the control group (p less than 0.05). The twins with complement-fixing islet cell antibodies had reduced glucose tolerance and clearance, whilst the twins without islet cell antibodies did not. Neither group of twins showed any abnormality in insulin, C-peptide or proinsulin response to oral or intravenous glucose. We conclude that increased fasting proinsulin levels precede abnormalities of insulin secretion, and are an early indication of minor B-cell damage in these twins irrespective of their risk of developing diabetes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3286344     DOI: 10.1007/bf00276853

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  9 in total

1.  Immune changes associated with insulin dependent diabetes may remit without causing the disease: a study in identical twins.

Authors:  B A Millward; L Alviggi; P J Hoskins; C Johnston; D Heaton; G F Bottazzo; D Vergani; R D Leslie; D A Pyke
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-22

2.  A micro enzyme-linked immunosorbent assay for insulin antibodies in serum.

Authors:  T Wilkin; S Nicholson; C Casey
Journal:  J Immunol Methods       Date:  1985-01-21       Impact factor: 2.303

3.  Diabetes in identical twins. A study of 200 pairs.

Authors:  A H Barnett; C Eff; R D Leslie; D A Pyke
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

4.  Type I (insulin dependent) diabetes: a disease of slow clinical onset?

Authors:  A C Tarn; C P Smith; K M Spencer; G F Bottazzo; E A Gale
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-07

5.  Evidence of beta cell dysfunction which does not lead on to diabetes: a study of identical twins of insulin dependent diabetics.

Authors:  D A Heaton; B A Millward; P Gray; Y Tun; C N Hales; D A Pyke; R D Leslie
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-17

6.  Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose.

Authors:  S Srikanta; O P Ganda; R E Gleason; R A Jackson; J S Soeldner; G S Eisenbarth
Journal:  Diabetes       Date:  1984-08       Impact factor: 9.461

7.  Pathogenesis of insulin-dependent diabetes: a role for activated T lymphocytes.

Authors:  L Alviggi; C Johnston; P J Hoskins; D E Tee; D A Pyke; R D Leslie; D Vergani
Journal:  Lancet       Date:  1984-07-07       Impact factor: 79.321

8.  Ten-year prognosis of impaired glucose tolerance in siblings of patients with insulin-dependent diabetes.

Authors:  A L Rosenbloom; S S Hunt; E K Rosenbloom; N K Maclaren
Journal:  Diabetes       Date:  1982-05       Impact factor: 9.461

9.  Characterization and use in immunoradiometric assay of monoclonal antibodies directed against human proinsulin.

Authors:  I P Gray; K Siddle; B H Frank; C N Hales
Journal:  Diabetes       Date:  1987-06       Impact factor: 9.461

  9 in total
  20 in total

1.  Escaping insulin dependent diabetes.

Authors:  R D Leslie; D A Pyke
Journal:  BMJ       Date:  1991-05-11

2.  Proinsulin conversion intermediates: a possible source of confusion.

Authors:  P A Halban
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

3.  Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release.

Authors:  K Hostens; D Pavlovic; Y Zambre; Z Ling; C Van Schravendijk; D L Eizirik; D G Pipeleers
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

4.  Proinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes.

Authors:  Renecia A Watkins; Carmella Evans-Molina; Jennifer K Terrell; Kathleen H Day; Lynette Guindon; Ivan A Restrepo; Raghavendra G Mirmira; Janice S Blum; Linda A DiMeglio
Journal:  Transl Res       Date:  2015-09-04       Impact factor: 7.012

5.  Experimental autoimmune insulitis. Induction by T lymphocytes specific for a peptide of proinsulin.

Authors:  A C Griffin; W Zhao; K W Wegmann; W F Hickley
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

6.  A sensitive and reliable method for assaying true human insulin without interaction with human proinsulin-like molecules.

Authors:  L D Monti; E P Sandoli; V C Phan; P M Piatti; S Costa; A Secchi; G Pozza
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

7.  Islet-cell antibodies as predictors of the later development of type 1 (insulin-dependent) diabetes. A study in identical twins.

Authors:  C Johnston; B A Millward; P Hoskins; R D Leslie; G F Bottazzo; D A Pyke
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

8.  Hyperinsulinaemia in obesity is not accompanied by an increase in serum proinsulin/insulin ratio in groups of human subjects with and without glucose intolerance.

Authors:  I Shiraishi; Y Iwamoto; T Kuzuya; A Matsuda; S Kumakura
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

9.  Proinsulin levels in newborn siblings of type 1 (insulin-dependent) diabetic children and their mothers.

Authors:  F A Lindgren; S G Hartling; B E Persson; M E Röder; K Snellman; C Binder; G Dahlquist
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

10.  Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies.

Authors:  K Böhmer; H Keilacker; B Kuglin; A Hübinger; J Bertrams; F A Gries; H Kolb
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.